Furthermore, since CD8+ T cells contribute the development of hypertension (37, 38), inhibition the overreactive CD8+ T cells may also protect heart through attenuating systolic hypertension in clinical setting or in rodents in response to systolic overload produced by angiotensin II or DOCA salt. The gene discussed is CD8A; the disease is hypertensive disorder.